By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Oxford Nanopore Technologies plc

Oxford Nanopore Technologies plc (ONT.L)

LSE Currency in GBP
£150.70
-£0.80
-0.53%
Last Update: 16 Jul 2025, 17:56
£1.45B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£88.60 - £169.20
52 Week Range

ONT.L Stock Price Chart

Explore Oxford Nanopore Technologies plc interactive price chart. Choose custom timeframes to analyze ONT.L price movements and trends.

There is nothing to show.

ONT.L Company Profile

Discover essential business fundamentals and corporate details for Oxford Nanopore Technologies plc (ONT.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

30 Sept 2021

Employees

1.38K

CEO

Gurdial Singh Sanghera

Description

Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.

ONT.L Financial Timeline

Browse a chronological timeline of Oxford Nanopore Technologies plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 2 Mar 2026

Upcoming earnings on 2 Sept 2025

Earnings released on 4 Mar 2025

EPS came in at -£0.08 surpassing the estimated -£0.10 by +23.41%, while revenue for the quarter reached £99.11M, missing expectations by -1.48%.

Earnings released on 3 Sept 2024

EPS came in at -£0.09 falling short of the estimated -£0.08 by -8.31%, while revenue for the quarter reached £84.08M, beating expectations by +0.10%.

Earnings released on 6 Mar 2024

EPS came in at -£0.10 falling short of the estimated -£0.05 by -104.48%, while revenue for the quarter reached £83.67M, missing expectations by -1.57%.

Earnings released on 6 Sept 2023

EPS came in at -£0.08 falling short of the estimated -£0.07 by -21.13%, while revenue for the quarter reached £86.00M, missing expectations by -0.29%.

Earnings released on 31 Dec 2022

EPS came in at -£0.07 falling short of the estimated -£0.06 by -23.03%, while revenue for the quarter reached £76.26M, missing expectations by -0.97%.

Earnings released on 30 Jun 2022

EPS came in at -£0.04 surpassing the estimated -£0.08 by +54.15%, while revenue for the quarter reached £122.35M, beating expectations by +68.76%.

Earnings released on 31 Dec 2021

EPS came in at -£0.15 falling short of the estimated -£0.09 by -66.06%, while revenue for the quarter reached £74.71M, beating expectations by +11.51%.

Earnings released on 30 Jun 2021

EPS came in at -£0.06, while revenue for the quarter reached £58.95M.

Earnings released on 31 Dec 2020

EPS came in at -£0.03, while revenue for the quarter reached £65.55M.

ONT.L Stock Performance

Access detailed ONT.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
ONT.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
ONT.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More